NCT06486012 Regular Use of aPDT in the Management and Prevention of Periodontitis Symptoms in Diabetic Patients
| NCT ID | NCT06486012 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Wellbeing Services County of Pirkanmaa |
| Condition | Diabetes Mellitus, Type 2 |
| Study Type | INTERVENTIONAL |
| Enrollment | 150 participants |
| Start Date | 2025-01-23 |
| Primary Completion | 2027-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 150 participants in total. It began in 2025-01-23 with a primary completion date of 2027-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is an investigator-initiated clinical study to establish easy referral and access for diabetic patients from primary health care to oral health care facilities for preventive oral care, periodontal assessment, and treatment, and to investigate the impact of regular home use of aPDT medical device on plaque control and gingival health, when used as an adjunct treatment to standard oral hygiene, and the effect on diabetes control in patients with the risk of periodontal disease, compared to a standard home care oral hygiene regimen.
Eligibility Criteria
Inclusion Criteria: * Diabetic patient treated at community health care; * At least 18 years old; * Presence of ≥20 teeth; * Agreement to participate in the study, and to sign a written consent form; * Ability to cooperate with the treatment protocol according to coordinator investigator's assessment. Exclusion Criteria: * Oral thrush; * Known sensitivity to near-infrared or antibacterial blue light.
Contact & Investigator
Anna Maria Heikkinen, Professor
PRINCIPAL INVESTIGATOR
Wellbeing Services of County Pirkanmaa
Frequently Asked Questions
Who can join the NCT06486012 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Diabetes Mellitus, Type 2. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06486012 currently recruiting?
Yes, NCT06486012 is actively recruiting participants. Contact the research team at miia.ehrnrooth@mehilainen.fi for enrollment information.
Where is the NCT06486012 trial being conducted?
This trial is being conducted at Tampere, Finland.
Who is sponsoring the NCT06486012 clinical trial?
NCT06486012 is sponsored by Wellbeing Services County of Pirkanmaa. The principal investigator is Anna Maria Heikkinen, Professor at Wellbeing Services of County Pirkanmaa. The trial plans to enroll 150 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.